Longmont, CO, United States of America

Jian Qiu

USPTO Granted Patents = 38 


 

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 175(Granted Patents)


Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
Loading Chart...
38 patents (USPTO):Explore Patents

Innovative Contributions of Jian Qiu in Pharmaceutical Patents

Introduction

Jian Qiu, based in Longmont, Colorado, is a prolific inventor known for his significant contributions to the pharmaceutical industry, particularly in the area of S-nitrosoglutathione reductase inhibitors. With an impressive portfolio of 38 patents, his work continues to pave the way for innovative treatments that leverage his expertise in medicinal chemistry.

Latest Patents

Among his latest patents, Jian Qiu has developed innovative solid forms of an S-nitrosoglutathione reductase inhibitor. This invention provides solid forms and compositions that serve as effective inhibitors of S-nitrosoglutathione reductase, showcasing desirable characteristics for pharmaceutical applications. Another noteworthy patent involves substituted quinoline compounds, which are novel compounds utilized as S-nitrosoglutathione reductase inhibitors. This patent includes pharmaceutical compositions that comprise these compounds and outlines methods for their synthesis and application.

Career Highlights

Throughout his career, Jian Qiu has worked with esteemed companies including Nivalis Therapeutics, Inc. and N30 Pharmaceuticals, Inc. His work has significantly impacted drug development in the field of pharmacology, especially concerning therapeutic strategies against various health conditions.

Collaborations

Jian has collaborated with notable professionals such as Xicheng David Sun and Jan William Wasley. These collaborations have not only enhanced his reach in the pharmaceutical domain but have also fostered a rich exchange of knowledge and ideas among experts in the field.

Conclusion

In conclusion, Jian Qiu's inventive approach and dedication to developing S-nitrosoglutathione reductase inhibitors highlight his role as a key figure in pharmaceutical innovation. With a continuing focus on enhancing medicinal compounds, his patents contribute significantly to advancing therapeutic options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…